A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

NCT06628362 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obese
Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Placebo
DRUG: Enicepatide

Sponsor

Carmot Therapeutics, Inc.

Collaborators

[object Object]